Status:
COMPLETED
Complement Activation During Hemodialysis in Atypical Hemolytic Uraemic Syndrome as Underlying Kidney Disease
Lead Sponsor:
University Hospital, Ghent
Conditions:
Atypical Hemolytic Uraemic Syndrome
Eligibility:
All Genders
18+ years
Brief Summary
Atypical hemolytic uraemic syndrome is caused by defects in the regulating factors in the alternative pathway of the complement system. Triggering can cause an uncontrolled complement activation with ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- cases: endstage renal failure due to atypical hemolytic uraemic syndrome treated with hemodialysis.
- controls: endstage renal failure due to a non complement consuming nephropathy treated with hemodialysis.
Exclusion
Key Trial Info
Start Date :
August 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2015
Estimated Enrollment :
25 Patients enrolled
Trial Details
Trial ID
NCT00930423
Start Date
August 1 2009
End Date
July 1 2015
Last Update
December 15 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Ghent
Ghent, Belgium, 9000